Chronic spontaneous urticaria treatment with Benralizumab. Benralizumab을 이용한 만성 자발성 두드러기 치료
chronic spontaneous urticaria treatment with Benralizumab. Benralizumab을 이용한 만성 자발성 두드러기 치료 Benralizumab, an anti–interleukin-5-receptor antibody, was evaluated in a 24-week study involving 12 patients with chronic spontaneous urticaria. The disease was assessed on the basis of urticaria activity … Continued